Gene · 1022
Papers3,996
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,996
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptome-conditioned molecule generation via gene interaction-aware fragment modeling with a GPT-based architecture. | Sci Rep | 2025 | 41188290 | PubTator, text mining | PubMed |
| CENP-F promotes HCC cell proliferation mediated by super enhancer reader BRD4. | Discov Oncol | 2025 | 41160272 | PubTator, text mining | PubMed |
| Recent advances in development of CDK7 inhibitors and their clinical trials: a narrative review. | Transl Cancer Res | 2025 | 41158223 | PubTator, text mining | PubMed |
| New Assay Systems to Characterize the Broad-Spectrum Antiherpesviral and Non-Herpesviral Activity of Cyclin-Dependent Kinase (CDK) 8 Inhibitors. | Pharmaceuticals (Basel) | 2025 | 41155676 | PubTator, text mining | PubMed |
| Structural basis of T-loop-independent recognition and activation of CDKs by the CDK-activating kinase. | Science | 2025 | 41100585 | Swiss-Prot, curated | PubMed |
| FAIM modulates HCC progression via enhancing HMGA1 interaction with CDK7 and promoting its phosphorylation level. | J Transl Med | 2025 | 41094644 | PubTator, text mining | PubMed |
| CDK7 as a New therapeutic target in pancreatic and lung cancer: current evidence and future perspectives. | Expert Opin Ther Targets | 2025 | 41060826 | PubTator, text mining | PubMed |
| Dual Modes of Gene Regulation by CDK12. | bioRxiv | 2025 | 41040222 | PubTator, text mining | PubMed |
| Multi-target pharmacological mechanisms of Iris tectorum Maxim. (CSG) against tonsillitis and dyspepsia: A network pharmacology approach. | Medicine (Baltimore) | 2025 | 41029077 | PubTator, text mining | PubMed |
| Loss of the tumor suppressor PTEN activates cell-intrinsic interferon signaling to drive immune resistance. | bioRxiv | 2025 | 41000885 | PubTator, text mining | PubMed |
| Transcription quality control at the promoter-proximal checkpoint. | Genes Dev | 2025 | 40973501 | PubTator, text mining | PubMed |
| [Regulatory Role of the AKT1/AMPK Pathway in Oxidative Stress of Lens Epithelial Cells in Cataract Patients]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2025 | 40964109 | PubTator, text mining | PubMed |
| Cryptic splicing in synaptic and membrane excitability genes links TDP-43 loss to neuronal dysfunction. | bioRxiv | 2025 | 40949955 | PubTator, text mining | PubMed |
| Resistance to CDK7 inhibitors directed by acquired mutation of a conserved residue in cancer cells. | EMBO J | 2025 | 40921851 | PubTator, text mining | PubMed |
| Charting the Multi-level Molecular Response to Palbociclib in ER-Positive Breast Cancer. | bioRxiv | 2025 | 40909606 | PubTator, text mining | PubMed |
| Targeting the TRIB3-MYC axis in cancer: mechanistic insights and therapeutic disruption strategies. | Invest New Drugs | 2025 | 40903666 | PubTator, text mining | PubMed |
| Focal adhesion kinase/Src family kinase axis-mediated tyrosine phosphorylation of metabolic enzymes facilitates tumor metastasis. | Signal Transduct Target Ther | 2025 | 40887473 | PubTator, text mining | PubMed |
| Novel Pyrazolo [1,5-a]-1,3,5-Triazine Derivatives as CDK7 Inhibitors: Synthesis and Biological Insights in Pancreatic Ductal Adenocarcinoma Models. | ChemMedChem | 2025 | 40853714 | PubTator, text mining | PubMed |
| The novel role of DUSP4 in suppressing ferroptosis and promoting cytotoxicity of CD8+ T cells in MSI colorectal cancer. | Br J Cancer | 2025 | 40847010 | PubTator, text mining | PubMed |
| Super-enhancer inhibitors THZ2 and JQ1 reverse temozolomide resistance in glioblastoma by suppressing SE-driven SOX9 expression. | Cancer Drug Resist | 2025 | 40843352 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1022/papers?page=5